Reem A. AlQarni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Reem A. AlQarni has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah Almaqhawi
Department of Family and Community Medicine, College of Medicine, King Faisal University
1 shared publication - Abdulrhman Khaled Al Abdulqader
Department of Internal Medicine, College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia
1 shared publication - Ahmed Albadrani
Department of Internal Medicine, College of Medicine, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia
1 shared publication Dhiyaa A. Almusaylim
College of Medicine and Surgery, King Faisal University, Al Ahsa, SAU
1 shared publication- Doaa Alabdulkarim
College of Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia
1 shared publication Eman Abdullah
Rheumatology, King Faisal University, Al Ahsa, SAU
1 shared publication
Latest Publications
- Open Access
- 28 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 6868
Relapse Rates and Predictors Following Azathioprine Withdrawal in Inflammatory Bowel Disease: A Systematic Review, Meta-Analysis, and Meta-Regression
Background/Objectives: Azathioprine (AZA) is widely used for maintaining remission in inflammatory bowel disease (IBD), but the implications of its withdrawal remain unclear. This study evaluates relapse rates after AZA discontinuation in adult IBD patients in remission and identifies predictors of relapse. Methods: A systematic review and meta-analysis were conducted according to PRISMA 2020 guidelines and registered in PROSPERO (CRD420251016594). Databases were searched from inception to 4 January 2025, including RCTs and cohort studies involving adult IBD patients who discontinued AZA in clinical remission. The main outcome assessed was relapse incidence, with additional outcomes covering time until relapse, predictors of relapse, and management following relapse. Random-effects meta-analysis, subgroup analyses, and meta-regression were performed. Results: Twenty-two studies comprising 3057 patients were included. The pooled relapse rate after AZA withdrawal was 32.5% (95% CI: 28.2–37.2%; I2 = 94.2%). UC patients exhibited higher relapse rates (41.3%) than CD patients (24.7%, p = 0.003). Shorter AZA duration, elevated CRP, and absence of mucosal healing were associated with increased relapse risk. Meta-regression identified AZA duration as a significant predictor (β = −0.18, p = 0.009). Post-relapse management often involved AZA reintroduction or escalation to biologics, with low surgery rates. The GRADE assessment revealed that the certainty of evidence for the majority of primary outcomes was classified as low to very low. Conclusions: While this meta-analysis suggests that relapse after AZA withdrawal occurs frequently in IBD patients, the low to very low certainty of evidence limits definitive recommendations. The significant heterogeneity indicates that relapse risk varies across different patient populations and different settings.
- 28 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 6868
Open AccessRelapse Rates and Predictors Following Azathioprine Withdrawal in Inflammatory Bowel Disease: A Systematic Review, Meta-Analysis, and Meta-Regression
Background/Objectives: Azathioprine (AZA) is widely used for maintaining remission in inflammatory bowel disease (IBD), but the implications of its withdrawal remain unclear. This study evaluates relapse rates after AZA discontinuation in adult IBD patients in remission and identifies predictors of relapse. Methods: A systematic review and meta-analysis were conducted according to PRISMA 2020 guidelines and registered in PROSPERO (CRD420251016594). Databases were searched from inception to 4 January 2025, including RCTs and cohort studies involving adult IBD patients who discontinued AZA in clinical remission. The main outcome assessed was relapse incidence, with additional outcomes covering time until relapse, predictors of relapse, and management following relapse. Random-effects meta-analysis, subgroup analyses, and meta-regression were performed. Results: Twenty-two studies comprising 3057 patients were included. The pooled relapse rate after AZA withdrawal was 32.5% (95% CI: 28.2–37.2%; I2 = 94.2%). UC patients exhibited higher relapse rates (41.3%) than CD patients (24.7%, p = 0.003). Shorter AZA duration, elevated CRP, and absence of mucosal healing were associated with increased relapse risk. Meta-regression identified AZA duration as a significant predictor (β = −0.18, p = 0.009). Post-relapse management often involved AZA reintroduction or escalation to biologics, with low surgery rates. The GRADE assessment revealed that the certainty of evidence for the majority of primary outcomes was classified as low to very low. Conclusions: While this meta-analysis suggests that relapse after AZA withdrawal occurs frequently in IBD patients, the low to very low certainty of evidence limits definitive recommendations. The significant heterogeneity indicates that relapse risk varies across different patient populations and different settings.
- Open Access
- 13 September 2024
- Published by Springer Nature in Cureus
- Vol. 16 (9)
Public Awareness and Attitudes Toward Lifestyle Modifications for Controlling Osteoarthritis and Their Relationship to Cardiovascular Risk Factors
Background Osteoarthritis (OA), common in older adults, leads to joint degradation and inflammation, with risk factors including age, obesity, and genetics. OA strongly indicates cardiovascular disease (CVD), with shared risk factors such as lack of exercise and muscle weakness. This study explores the awareness of OA and its relationship to CVD risk factors. Methodology This cross-sectional study in Al Ahsa, Saudi Arabia, involved an online self-administered questionnaire distributed via Google Forms to randomly selected adults, with ages ranging from 18 to 65 years. Informed consent was taken from all participants. Data was cleaned in Excel and analyzed using SPSS version 29 (IBM Corp., Armonk, NY, USA). Results Our study assessed the awareness of 381 participants about the relationship between OA and CVD. Most participants were female 312 (81.9%). Overall, 250 (65.6%) participants were aged 18-27, and 362 (95.0%) were Saudi nationals. Further, 210 (55.1%) participants had a bachelor’s degree, and 223 (58.5%) were students. Healthcare exposure varied, with 207 (54.3%) having no background, and 157 (41.2%) being healthcare students. Notably, 152 (39.9%) knew someone diagnosed with OA, of whom 55 (14.4%) also had CVD. Significant predictors of awareness included studying in healthcare (Exp(B) = 3.325, p = 0.001), receiving OA information (Exp(B) = 2.222, p = 0.007), sources such as school/university (Exp(B) = 7.851, p = 0.000), and personal experience (Exp(B) = 4.768, p = 0.034). Conclusions This study showed a notable gap in awareness about the link between OA and CVD in Al Ahsa, Saudi Arabia. While those with healthcare exposure showed good knowledge, many lacked an understanding of their relationship. Targeted education, particularly for younger and non-healthcare-educated groups, is crucial for improving awareness and promoting effective lifestyle modifications to manage both OA and CVD risks.
- 13 September 2024
- Published by Springer Nature in Cureus
- Vol. 16 (9)
Open AccessPublic Awareness and Attitudes Toward Lifestyle Modifications for Controlling Osteoarthritis and Their Relationship to Cardiovascular Risk Factors
Background Osteoarthritis (OA), common in older adults, leads to joint degradation and inflammation, with risk factors including age, obesity, and genetics. OA strongly indicates cardiovascular disease (CVD), with shared risk factors such as lack of exercise and muscle weakness. This study explores the awareness of OA and its relationship to CVD risk factors. Methodology This cross-sectional study in Al Ahsa, Saudi Arabia, involved an online self-administered questionnaire distributed via Google Forms to randomly selected adults, with ages ranging from 18 to 65 years. Informed consent was taken from all participants. Data was cleaned in Excel and analyzed using SPSS version 29 (IBM Corp., Armonk, NY, USA). Results Our study assessed the awareness of 381 participants about the relationship between OA and CVD. Most participants were female 312 (81.9%). Overall, 250 (65.6%) participants were aged 18-27, and 362 (95.0%) were Saudi nationals. Further, 210 (55.1%) participants had a bachelor’s degree, and 223 (58.5%) were students. Healthcare exposure varied, with 207 (54.3%) having no background, and 157 (41.2%) being healthcare students. Notably, 152 (39.9%) knew someone diagnosed with OA, of whom 55 (14.4%) also had CVD. Significant predictors of awareness included studying in healthcare (Exp(B) = 3.325, p = 0.001), receiving OA information (Exp(B) = 2.222, p = 0.007), sources such as school/university (Exp(B) = 7.851, p = 0.000), and personal experience (Exp(B) = 4.768, p = 0.034). Conclusions This study showed a notable gap in awareness about the link between OA and CVD in Al Ahsa, Saudi Arabia. While those with healthcare exposure showed good knowledge, many lacked an understanding of their relationship. Targeted education, particularly for younger and non-healthcare-educated groups, is crucial for improving awareness and promoting effective lifestyle modifications to manage both OA and CVD risks.